Market Cap 30.79M
Revenue (ttm) 640,000.00
Net Income (ttm) -57.78M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -9,028.13%
Debt to Equity Ratio 0.00
Volume 144,000
Avg Vol 33,063
Day's Range N/A - N/A
Shares Out 5.28M
Stochastic %K 85%
Beta -1.05
Analysts Sell
Price Target $8.00

Company Profile

Rallybio Corporation, a clinical-stage biotechnology company, engages in development and commercialization of life-transforming therapies for patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody which is in Phase II clinical trial for the prevention of fetal and neonatal alloimmune thrombocytopenia (FNAIT); and RLYB211 for the prevention of FNAIT. The company is also developing RLYB114, a pegylated complement factor 5 (C5)-tar...

Industry: Biotechnology
Sector: Healthcare
Phone: 203 859 3820
Address:
234 Church Street, Suite 1020, New Haven, United States
SDBiotechInvestor
SDBiotechInvestor Feb. 25 at 10:30 PM
$RLYB - volume precedes price. Interesting few days ahead.
0 · Reply
_KingVictorX
_KingVictorX Feb. 25 at 7:50 PM
0 · Reply
3xMooners
3xMooners Feb. 25 at 7:37 PM
0 · Reply
skyrockets_Inc
skyrockets_Inc Feb. 25 at 7:02 PM
$RLYB cont. from post below. 4). Data released Feb 14. Good efficacy and safety. Now company can talk again and is out of 'black period' . Now that they know plan going forward they can now share data with potential investors (PIPE theory) and/or suitors (parnter/buyout theory). Hence the 'clock' started on Feb 17. From Jan to Feb 17 they did not even know the future of their own company. Makes no sense that they would be sharing data w/ investors at this point. 5). Since data: Stock has rallied almost 50% . Constant buying pressure and volume pushing stock up to closer and closer to intrinsic value. Following the $RGLS example. Data , no reaction, then price adjustment. Then the buyout came for $RGLS a month later. Investors are just now seeing the data for the first time and a deal should take 30-60 days to complete. Expecting something soon . Price action seems to corroberate my theory as well. GLTA !
0 · Reply
skyrockets_Inc
skyrockets_Inc Feb. 25 at 7:00 PM
$RLYB Timeline of Events and Theory for Buyout / PIPE coming soon: 1). 150mg Cohort 1 full 14 week data efficacy and safety data received early Dec 2025 --> efficacy was not as strong as they had hoped and so they decided internally they needed to complete Cohort 2 (300 mg) 2). 300mg Cohort 2 4 week topline data (w/o long term safety) received mid Dec 2025. Efficacy was great but long term safety unknown. Initially guided to release data end of Dec, but because long term safety on 300mg dose had never been completed they needed to hold release of data until 10 week follow up safety data was complete (hence delay). 3). Data delay: Timeframe from Jan - early Feb. Company waiting on long term safety data for 300mg. Company silent in 'black period' during this time because at this stage they did not know results. If safety issues came up then company would have to shut down/announce strat alts. Company chose to be silent until data. Hence no potential partners were viewing at this time.
0 · Reply
SDBiotechInvestor
SDBiotechInvestor Feb. 25 at 5:55 PM
$RLYB strong accumulation. May be the investment bank about to initiate coverage
0 · Reply
joe77w
joe77w Feb. 24 at 8:33 PM
$RLYB 10 USD likely even without news, only to reflect cash position, no debt. RLYB 116 MM may address 5 bln USD + nn markets
0 · Reply
3xMooners
3xMooners Feb. 24 at 7:31 PM
Caught a few of @TheMorningStew alerts over the last few weeks that went crazy! Give him a follow 🔥 $EDHL $RLYB $PRFX $ASST Soon..
0 · Reply
topstockalerts
topstockalerts Feb. 24 at 5:28 PM
$RLYB Relative strength remains high. Buyers continue to support price on pullbacks. This trend is intact.
0 · Reply
skyrockets_Inc
skyrockets_Inc Feb. 24 at 4:53 PM
$RLYB The trend was clear and obvious when amazing data was released. Up 33% since the post below. This will continue to 'drift toward cash value' as @estatebuyersmia told us! $10/share incoming organically :)
0 · Reply
Latest News on RLYB
Rallybio Announces Reverse Stock Split of Common Stock

Feb 3, 2026, 4:05 PM EST - 22 days ago

Rallybio Announces Reverse Stock Split of Common Stock


Why Is Microcap Rallybio Stock Trading Higher On Tuesday?

Jul 8, 2025, 9:44 AM EDT - 8 months ago

Why Is Microcap Rallybio Stock Trading Higher On Tuesday?


National Vision Releases 2023 Sustainability Report

Aug 27, 2024, 8:00 AM EDT - 1 year ago

National Vision Releases 2023 Sustainability Report

ACNT


Rallybio to Present at Upcoming Investor Conferences

Aug 27, 2024, 8:00 AM EDT - 1 year ago

Rallybio to Present at Upcoming Investor Conferences


SDBiotechInvestor
SDBiotechInvestor Feb. 25 at 10:30 PM
$RLYB - volume precedes price. Interesting few days ahead.
0 · Reply
_KingVictorX
_KingVictorX Feb. 25 at 7:50 PM
0 · Reply
3xMooners
3xMooners Feb. 25 at 7:37 PM
0 · Reply
skyrockets_Inc
skyrockets_Inc Feb. 25 at 7:02 PM
$RLYB cont. from post below. 4). Data released Feb 14. Good efficacy and safety. Now company can talk again and is out of 'black period' . Now that they know plan going forward they can now share data with potential investors (PIPE theory) and/or suitors (parnter/buyout theory). Hence the 'clock' started on Feb 17. From Jan to Feb 17 they did not even know the future of their own company. Makes no sense that they would be sharing data w/ investors at this point. 5). Since data: Stock has rallied almost 50% . Constant buying pressure and volume pushing stock up to closer and closer to intrinsic value. Following the $RGLS example. Data , no reaction, then price adjustment. Then the buyout came for $RGLS a month later. Investors are just now seeing the data for the first time and a deal should take 30-60 days to complete. Expecting something soon . Price action seems to corroberate my theory as well. GLTA !
0 · Reply
skyrockets_Inc
skyrockets_Inc Feb. 25 at 7:00 PM
$RLYB Timeline of Events and Theory for Buyout / PIPE coming soon: 1). 150mg Cohort 1 full 14 week data efficacy and safety data received early Dec 2025 --> efficacy was not as strong as they had hoped and so they decided internally they needed to complete Cohort 2 (300 mg) 2). 300mg Cohort 2 4 week topline data (w/o long term safety) received mid Dec 2025. Efficacy was great but long term safety unknown. Initially guided to release data end of Dec, but because long term safety on 300mg dose had never been completed they needed to hold release of data until 10 week follow up safety data was complete (hence delay). 3). Data delay: Timeframe from Jan - early Feb. Company waiting on long term safety data for 300mg. Company silent in 'black period' during this time because at this stage they did not know results. If safety issues came up then company would have to shut down/announce strat alts. Company chose to be silent until data. Hence no potential partners were viewing at this time.
0 · Reply
SDBiotechInvestor
SDBiotechInvestor Feb. 25 at 5:55 PM
$RLYB strong accumulation. May be the investment bank about to initiate coverage
0 · Reply
joe77w
joe77w Feb. 24 at 8:33 PM
$RLYB 10 USD likely even without news, only to reflect cash position, no debt. RLYB 116 MM may address 5 bln USD + nn markets
0 · Reply
3xMooners
3xMooners Feb. 24 at 7:31 PM
Caught a few of @TheMorningStew alerts over the last few weeks that went crazy! Give him a follow 🔥 $EDHL $RLYB $PRFX $ASST Soon..
0 · Reply
topstockalerts
topstockalerts Feb. 24 at 5:28 PM
$RLYB Relative strength remains high. Buyers continue to support price on pullbacks. This trend is intact.
0 · Reply
skyrockets_Inc
skyrockets_Inc Feb. 24 at 4:53 PM
$RLYB The trend was clear and obvious when amazing data was released. Up 33% since the post below. This will continue to 'drift toward cash value' as @estatebuyersmia told us! $10/share incoming organically :)
0 · Reply
joe77w
joe77w Feb. 24 at 4:22 PM
$RLYB After stellar clinical Trial results 20 PT imo
0 · Reply
joe77w
joe77w Feb. 24 at 4:22 PM
$RLYB 6.1 news out ah likely imo, we are waiting for corporate update earnings
0 · Reply
OnyxPredator
OnyxPredator Feb. 24 at 1:05 AM
.@SqueezeSharkie is operating on a whole different level, easily ahead of 90% of the traders on this platform. .If you’re not paying attention yet, you’re missing out. Go give him a .follow. It’s completely free and only takes a second 💎 $TARA $RLYB $ANGH $MB &
0 · Reply
skyrockets_Inc
skyrockets_Inc Feb. 23 at 7:00 PM
$RLYB Insider Purchases!! Two directors (Martin McKay and Ronald Hunt) filed Form 4's over the weekend indicating that they elected to purchase company stock instead of receiving their retainer salary for being on the BOD. Martin McKay (shown below) elected to purchase 18,000 shares of stock instead of receiving his $65,000 cash salary. Ronald Hunt did the same thing. SUPER BULLISH! Insiders on the BOD are buying more because they know what's coming soon :)
0 · Reply
OnyxPredator
OnyxPredator Feb. 23 at 4:04 PM
0 · Reply
OnyxPredator
OnyxPredator Feb. 23 at 3:11 PM
$RSI $RLYB $SSL $CNDT >>>
0 · Reply
skyrockets_Inc
skyrockets_Inc Feb. 23 at 2:59 PM
$RLYB Agreed. This is one of the easiest investment decisions I've ever made tbh.
0 · Reply
SDBiotechInvestor
SDBiotechInvestor Feb. 23 at 2:44 PM
$RLYB will organically go to $10 by end of March imo
0 · Reply
_8xSasuke
_8xSasuke Feb. 23 at 12:00 PM
0 · Reply
joe77w
joe77w Feb. 21 at 3:39 PM
$RLYB https://news.cision.com/59-north-communications/r/affibody-s-licensee-rallybio-announces-positive-data-for-rlyb116-phase-1-study-demonstrating-complet,c4309543
0 · Reply
joe77w
joe77w Feb. 21 at 6:14 AM
$RLYB you are right, It Is a matter of weeks and we Will know much more. Co Is waiting for 5 mln USD from Recursion in the Summer plus potential proceeds from sale or outlicensing of other compounds. Cash alone around 9/10, RLY116 compound ready for a multibillion dollar market.
0 · Reply
skyrockets_Inc
skyrockets_Inc Feb. 20 at 9:03 PM
$RLYB Lot's of buying pressure today. Stock still incredibly undervalued. No plans to start Phase 2 trial until 2H 2026 which means likely exploring deal structures in the next few weeks/month. Price over next 2 weeks is going to be very telling. If it keeps drifting upward then I'm confident deal is in the works. Easy hold for now .
0 · Reply